4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-17-056202
SVP, Regulatory Affairs & Qual sold 11,500 shares at $50.00 ($575,000)
- SVP, Regulatory Affairs & Qual acquired 11,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ruff Shamim · SVP, Regulatory Affairs & Qual
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-10-03 | Exercise or conversion : show line 1 in the form | +11,500 | $14.76 | $169,740 | 38,545 | D |
| 2017-10-03 | Sale : show line 2 in the form | −11,500 | $50.00 | $575,000 | 27,045 | D |
| Open-market sales · 11,500 sh · avg $50.00 · $575,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2017-10-03 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Options (right to buy) | −11,500 | $14.76 | $169,740 | $14.76 | 2025-05-06 | 11,500 | 41,144 | D |
Loading xslF345X03/doc4.xml…